Ondansetron

5-hydroxytryptamine receptor 3A ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34467765 Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties. 2021 Sep 23 2
2 32250181 Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery. 2020 May 1
3 32899016 5-HT3 blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study. 2020 Sep 4 1
4 30797147 Potential roles of 5-HT3 receptor (5-HT3R) antagonists in modulating the effects of nicotine. 2019 Apr 1
5 27816366 Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial. 2017 Mar 1
6 26576669 Potential serotonergic agents for the treatment of schizophrenia. 2016 1
7 27677804 Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT3 A receptor. 2016 Dec 1
8 26565961 Galanin-Mediated Behavioural Hyperalgesia from the Dorsomedial Nucleus of the Hypothalamus Involves Two Independent Descending Pronociceptive Pathways. 2015 1
9 22458709 Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects. 2014 Mar 1
10 23126479 There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients. 2013 Jun 1
11 23321066 Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes. 2013 Apr 2
12 23897038 Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron. 2013 Sep 3
13 22644261 Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study. 2012 Sep 1
14 23050164 Assessment of ondansetron-associated hypokalemia in pediatric oncology patients. 2012 1
15 18670328 Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. 2008 Aug 1 1
16 17562330 Influence of immunomodulatory drugs on the cytotoxicity induced by monoclonal antibody 17-1A and interleukin-2. 2007 Mar 1
17 15554432 Fatigue complicating chronic liver disease. 2004 Dec 1
18 11212100 The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. 2001 Feb 12 1
19 11762972 Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. 2001 Nov 1
20 10997728 Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. 2000 Sep 1
21 8856622 Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. 1996 Aug 3
22 22298739 The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. 1995 Jan 1
23 8299095 The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. 1994 Feb 1 1
24 8347903 Use of ondansetron for control of projectile vomiting in patients with neurosurgical trauma: two case reports. 1993 May 1
25 1838490 [Ondansetron: a specific 5-HT3 serotonin receptor inhibitor, a new antiemetic in oncology]. 1991 1
26 1831542 Evaluation of the 5HT3 antagonist ondansetron (O) for cocaine (C)-like activity and abuse potential. 1990 1
27 2138064 Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan. 1990 1
28 2144721 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment. 1990 Aug 2
29 2525078 The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting. 1989 1